Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)

NCT01597505 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
606
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)